Protalix BioTherapeutics, Inc. Income (Loss) from Continuing Operations, Per Basic Share
Protalix BioTherapeutics, Inc. (PLX) reported Income (Loss) from Continuing Operations, Per Basic Share of $0.00 per share for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2017-08-09
- Protalix BioTherapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2017-06-30 was $0.00.
- Protalix BioTherapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2016-06-30 was -$0.11.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month |
|---|---|---|
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | -$0.47 10-Q · filed 2017-08-09 |
| 2016-06-30 | -$0.11 10-Q · filed 2017-08-09 | -$0.20 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |